TrialVaccine2011

Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months.

F M Russell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.